Showing results (521-530 of 744) with videos related to
Sort By:
Pageof 75
European Journal of Cancer (Oxford, England : 1990)|December 2, 2022
Measuring variation in the quality of systemic anti-cancer therapy delivery across hospitals: A national population-based evaluationJemma M Boyle, Jan van der Meulen, Angela Kuryba, et al.Clinical Chemistry|October 28, 1997
Multicenter evaluation of a second-generation assay for cardiac troponin TH Baum, S Braun, W Gerhardt, et al.The Journal of Chemical Physics|September 16, 2004
Core excitations of naphthalene: vibrational structure versus chemical shiftsI Minkov, F Gel'mukhanov, R Friedlein, et al.The New England Journal of Medicine|February 24, 2000
Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancerS Braun, K Pantel, P Müller, et al.Journal of Aerosol Medicine and Pulmonary Drug Delivery|June 4, 2008
Stabilizing formulations for inhalable powders of live-attenuated measles virus vaccineJessica L Burger, Stephen P Cape, Chad S Braun, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Phase I and pharmacokinetic study of intravenous irinotecan plus oral ciclosporin in patients with fuorouracil-refractory metastatic colon cancerJohn D Chester, Simon P Joel, Susan L Cheeseman, et al.Chest|April 1, 1996
A comparative study of the clinical efficacy of nedocromil sodium and placebo. How does cromolyn sodium compare as an active control treatment?H J Schwartz, M Blumenthal, R Brady, et al.Blood|December 29, 2006
K-RasG12D expression induces hyperproliferation and aberrant signaling in primary hematopoietic stem/progenitor cellsMargaret E M Van Meter, Ernesto Díaz-Flores, Joehleen A Archard, et al.Annals of Neurology|May 30, 2025
Machine Learning Models of Voxel-Level [18F] Fluorodeoxyglucose Positron Emission Tomography Data Excel at Predicting Progressive Supranuclear Palsy PathologyAddison S Braun, Ryota Satoh, Nha Trang Thu Pham, et al.Proceedings of the National Academy of Sciences of the United States of America|December 31, 2003
Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorderBenjamin S Braun, David A Tuveson, Namie Kong, et al.Pageof 75